NO894295L - Fremgangsmaate for behandling av interstitiell cystitt. - Google Patents

Fremgangsmaate for behandling av interstitiell cystitt.

Info

Publication number: NO894295L
Authority: NO; Norway
Prior art keywords: cystite; interstitially; procedure; treatment; naltrexone
Prior art date: 1988-11-01

Application number

NO89894295A

Other languages

English (en)

Norwegian (no)

Other versions

NO894295D0 (no

Inventor

Fred P Sherman

Original Assignee

Baker Cummins Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-11-01

Filing date

1989-10-27

Publication date

1990-05-02

1989-10-27 Application filed by Baker Cummins Pharma filed Critical Baker Cummins Pharma

1989-10-27 Publication of NO894295D0 publication Critical patent/NO894295D0/no

1990-05-02 Publication of NO894295L publication Critical patent/NO894295L/no

Links

238000000034 method Methods 0.000 title abstract 2
WJBLNOPPDWQMCH-MBPVOVBZSA-N Nalmefene Chemical compound N1([C@@H]2CC3=CC=C(C=4O[C@@H]5[C@](C3=4)([C@]2(CCC5=C)O)CC1)O)CC1CC1 WJBLNOPPDWQMCH-MBPVOVBZSA-N 0.000 abstract 2
229960005297 nalmefene Drugs 0.000 abstract 2
229960003086 naltrexone Drugs 0.000 abstract 2
DQCKKXVULJGBQN-XFWGSAIBSA-N naltrexone Chemical compound N1([C@@H]2CC3=CC=C(C=4O[C@@H]5[C@](C3=4)([C@]2(CCC5=O)O)CC1)O)CC1CC1 DQCKKXVULJGBQN-XFWGSAIBSA-N 0.000 abstract 2
208000005615 Interstitial Cystitis Diseases 0.000 abstract 1
239000003887 narcotic antagonist Substances 0.000 abstract 1
238000007911 parenteral administration Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Emergency Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Crystals, And After-Treatments Of Crystals (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Threshing Machine Elements (AREA)

NO89894295A 1988-11-01 1989-10-27 Fremgangsmaate for behandling av interstitiell cystitt. NO894295L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/265,575 US4877791A (en)	1988-11-01	1988-11-01	Method of treatment for interestitial cystitis

Publications (2)

Publication Number	Publication Date
NO894295D0 NO894295D0 (no)	1989-10-27
NO894295L true NO894295L (no)	1990-05-02

Family

ID=23011021

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO89894295A NO894295L (no)	1988-11-01	1989-10-27	Fremgangsmaate for behandling av interstitiell cystitt.

Country Status (11)

Country	Link
US (1)	US4877791A (de)
EP (1)	EP0367533B1 (de)
JP (1)	JPH07556B2 (de)
AT (1)	ATE102830T1 (de)
AU (1)	AU623189B2 (de)
CA (1)	CA2001996C (de)
DE (1)	DE68913907T2 (de)
DK (1)	DK541189A (de)
HK (1)	HK119994A (de)
NO (1)	NO894295L (de)
ZA (1)	ZA897823B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4857533A (en) *	1988-12-15	1989-08-15	Baker Cummins Pharmaceuticals, Inc.	Method of treatment for autoimmune diseases
US4994466A (en) *	1990-06-14	1991-02-19	Baker Cummins Pharmaceuticals, Inc.	Method of treatment for multiple sclerosis
US5057322A (en) *	1990-08-10	1991-10-15	Baker Cummins Dermatologicals, Inc.	Method of treating mast cell disease
US5145859A (en) *	1991-03-20	1992-09-08	Case Western Reserve University	Methods of treating interstitial cystitis and urethral syndrome
ES2214532T3 (es)	1995-03-03	2004-09-16	Endo Pharmaceuticals Inc.	Uso de dextrorfano o dextrometorfano para el tratamiento de la incontinencia urinaria.
US5878750A (en) *	1996-11-14	1999-03-09	Clemens; Anton H.	Method of treating the syndrome of coronary heart disease risk factors in humans
US6203813B1 (en)	1997-01-13	2001-03-20	Lance L. Gooberman	Pharmaceutical delivery device and method of preparation therefor
WO2000044390A1 (en) *	1999-02-01	2000-08-03	John Lezdey	Treatment of bladder and gastrointestinal mastocytosis
US6846831B2 (en)	2000-08-15	2005-01-25	Cpd, Llc	Method of treating the syndrome of lipodystrophy
US6262062B1 (en)	2000-08-15	2001-07-17	Cpd, Llc	Method of treating the syndrome of coronary heart disease risk factors in humans
US6528520B2 (en) *	2000-08-15	2003-03-04	Cpd, Llc	Method of treating the syndrome of coronary heart disease risk factors in humans
WO2002081477A1 (en) *	2001-03-30	2002-10-17	Toray Industries, Inc.	7-substituted morphinane derivatives and medicinal use thereof
US7501433B2 (en) *	2002-05-17	2009-03-10	Jenken Biosciences, Inc.	Opioid and opioid-like compounds and uses thereof
US6972291B2 (en) *	2002-07-02	2005-12-06	Bernstein Richard K	Method for reducing food intake
US8017622B2 (en) *	2003-05-16	2011-09-13	Jenken Biosciences, Inc.	Opioid and opioid-like compounds and uses thereof
DK2010220T3 (da) *	2006-04-03	2022-05-23	Ceva Animal Health Pty Ltd	Stabiliserede pentosanpolysulfat-(pps)-formuleringer
US9844533B2 (en) *	2008-12-16	2017-12-19	Hill's Pet Nutrition, Inc.	Antioxidant-containing food composition for use in inhibiting histamine pathways in companion animals
WO2019227053A1 (en) *	2018-05-25	2019-11-28	Adamis Pharmaceuticals Corporation	Drug compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE51145B1 (en) *	1980-03-07	1986-10-15	Efamol Ltd	Pharmaceutical and dietary compositions
EP0245366A1 (de) *	1985-10-29	1987-11-19	Baker Cummins Pharmaceuticals, Inc.	Verfahren und zusammensetzung zur blockierung der antigeninduzierten allergischen reaktionen
FR2609632B1 (fr) *	1987-01-21	1991-03-29	Shelly Marc	Nouvelle application therapeutique de la 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinon-6-one et les compositions pharmaceutiques destinees a cet usage
US4880813A (en) *	1988-07-22	1989-11-14	Baker Cummins Pharmaceuticals, Inc.	Method of treatment for allergic rhinitis
US4857533A (en) *	1988-12-15	1989-08-15	Baker Cummins Pharmaceuticals, Inc.	Method of treatment for autoimmune diseases

1988
- 1988-11-01 US US07/265,575 patent/US4877791A/en not_active Expired - Fee Related
1989
- 1989-10-16 ZA ZA897823A patent/ZA897823B/xx unknown
- 1989-10-25 JP JP1279638A patent/JPH07556B2/ja not_active Expired - Lifetime
- 1989-10-27 AU AU43850/89A patent/AU623189B2/en not_active Ceased
- 1989-10-27 NO NO89894295A patent/NO894295L/no unknown
- 1989-10-30 AT AT89311177T patent/ATE102830T1/de not_active IP Right Cessation
- 1989-10-30 DK DK541189A patent/DK541189A/da not_active Application Discontinuation
- 1989-10-30 DE DE68913907T patent/DE68913907T2/de not_active Expired - Fee Related
- 1989-10-30 EP EP89311177A patent/EP0367533B1/de not_active Expired - Lifetime
- 1989-11-01 CA CA002001996A patent/CA2001996C/en not_active Expired - Fee Related
1994
- 1994-11-03 HK HK119994A patent/HK119994A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0367533B1 (de)	1994-03-16
DK541189D0 (da)	1989-10-30
DE68913907D1 (de)	1994-04-21
AU4385089A (en)	1990-05-10
AU623189B2 (en)	1992-05-07
NO894295D0 (no)	1989-10-27
EP0367533A3 (de)	1991-10-02
ZA897823B (en)	1990-07-25
EP0367533A2 (de)	1990-05-09
DE68913907T2 (de)	1994-06-23
JPH02188525A (ja)	1990-07-24
JPH07556B2 (ja)	1995-01-11
CA2001996C (en)	1996-07-23
US4877791A (en)	1989-10-31
ATE102830T1 (de)	1994-04-15
HK119994A (en)	1994-11-11
CA2001996A1 (en)	1990-05-01
DK541189A (da)	1990-05-02

Publication	Publication Date	Title
ZA899028B (en)	1990-08-29	Compound for treatment for autoimmune diseases
NO894295L (no)	1990-05-02	Fremgangsmaate for behandling av interstitiell cystitt.
EP0377272A3 (de)	1991-09-25	Verwendung von Nalmefen oder Naltrexon zur Herstellung eines Arzneimittels zur Entzündungsbehandlung der Arthritis und assoziierter entzündlicher Erkrankungen
PT87542A (pt)	1989-05-31	Process for the preparation of a medicament based on indolone derivatives for the treatment of the parkinson disease
AU1189688A (en)	1988-08-10	Utilization of morphine antagonists in the preparation of drugs having an immunomodulator and antiviral effect, particularly for treating acquired immunodeficiency states
ATE78687T1 (de)	1992-08-15	Quaternaere derivate von noroxymorphon zur behandlung von uebelkeit und erbrechen.
EP0319962A3 (de)	1990-08-22	Piperidinyl-Methanol-Derivate zur Behandlung von Angstzuständen
ES2093357T3 (es)	1996-12-16	Metodo de tratamiento de la alopecia.
IL88740A (en)	1993-01-31	Pharmaceutical compositions containing n-n-butyl deoxynojirimycin for treating aids
AU8166291A (en)	1992-02-13	Method of treating mast cell disease
AU2908389A (en)	1989-07-19	Device for administering medicaments by atomization in intubated or tracheotomized patients
IT9086204A0 (it)	1990-05-31	Metodo per la cura dell'impotenza erettiva maschile
IT1224250B (it)	1990-09-26	Associzione del depiprazolo con la morfina
PT85593A (en)	1987-09-01	Process for preparing substituted hexahydroarylquinolizines
FI900098A0 (fi)	1990-01-09	Menetelmä lääkeaineena käyttökelpoisten 5H-pyrido/1',2':4,5/tiadiatsino/2,3-a/bentsimidatsoliumjohdannaisten valmistamiseksi
IL98200A0 (en)	1992-06-21	Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
IT8323253A0 (it)	1983-10-11	Preparato per la cura della crisi da astinenza nei tossicodipendenti.
RU92016264A (ru)	1995-05-20	Новые соединения, способ их получения, фармацевтический состав, его получение, способ профилактики или лечения, применение соединений